OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim, Manabu Emi, Kazuaki Tanabe
Immunology (2007) Vol. 121, Iss. 1, pp. 1-14
Open Access | Times Cited: 1021

Showing 1-25 of 1021 citing articles:

Hallmarks of Cancer: The Next Generation
Douglas Hanahan, Robert A. Weinberg
Cell (2011) Vol. 144, Iss. 5, pp. 646-674
Open Access | Times Cited: 59681

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener, et al.
Breast Care (2016) Vol. 11, Iss. 6, pp. 385-390
Open Access | Times Cited: 30355

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
Marloes J.M. Gooden, Geertruida H. de Bock, Ninke Leffers, et al.
British Journal of Cancer (2011) Vol. 105, Iss. 1, pp. 93-103
Open Access | Times Cited: 1189

Dendritic cell-based immunotherapy
Rachel Lubong Sabado, Sreekumar Balan, Nina Bhardwaj
Cell Research (2016) Vol. 27, Iss. 1, pp. 74-95
Open Access | Times Cited: 757

EPR: Evidence and fallacy
Joseph W. Nichols, You Han Bae
Journal of Controlled Release (2014) Vol. 190, pp. 451-464
Closed Access | Times Cited: 732

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy, Jeff D. Colbert, Kenneth L. Rock
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 670

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown, Robin M. Warren, Ewan A. Gibb, et al.
Genome Research (2014) Vol. 24, Iss. 5, pp. 743-750
Open Access | Times Cited: 576

B cell regulation in cancer and anti-tumor immunity
Anushruti Sarvaria, J. Alejandro Madrigal, Aurore Saudemont
Cellular and Molecular Immunology (2017) Vol. 14, Iss. 8, pp. 662-674
Open Access | Times Cited: 534

Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali, Leon Chlon, Paul D.P. Pharoah, et al.
PLoS Medicine (2016) Vol. 13, Iss. 12, pp. e1002194-e1002194
Open Access | Times Cited: 533

Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity
Ashley V. Kroll, Ronnie H. Fang, Yao Jiang, et al.
Advanced Materials (2017) Vol. 29, Iss. 47
Open Access | Times Cited: 452

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, Igor Vujic, Adil Daud, et al.
JAMA Dermatology (2015) Vol. 151, Iss. 11, pp. 1206-1206
Open Access | Times Cited: 423

Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer’s disease pathology
Kuti Baruch, Neta Rosenzweig, Alexander Kertser, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 414

Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition
Philip C. Calder, Nabil Bosco, Raphaëlle Bourdet‐Sicard, et al.
Ageing Research Reviews (2017) Vol. 40, pp. 95-119
Open Access | Times Cited: 408

Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
Salvatore Maria Corsello, Agnese Barnabei, Paolo Marchetti, et al.
The Journal of Clinical Endocrinology & Metabolism (2013) Vol. 98, Iss. 4, pp. 1361-1375
Open Access | Times Cited: 395

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
Marco Campoli, Soldano Ferrone
Oncogene (2008) Vol. 27, Iss. 45, pp. 5869-5885
Open Access | Times Cited: 379

Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Abhishek D. Garg, Patrizia Agostinis
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 126-148
Open Access | Times Cited: 371

Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence
Ritesh R. Kotecha, Akiyoshi Takami, J. Luis Espinoza
Oncotarget (2016) Vol. 7, Iss. 32, pp. 52517-52529
Open Access | Times Cited: 361

Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
Michaela K. Keck, Zhixiang Zuo, Arun Khattri, et al.
Clinical Cancer Research (2014) Vol. 21, Iss. 4, pp. 870-881
Open Access | Times Cited: 353

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
Aleksandra M. Dudek, Shaun Martin, Abhishek D. Garg, et al.
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 351

Immunosuppressive cells in tumor immune escape and metastasis
Yang Liu, Xuetao Cao
Journal of Molecular Medicine (2015) Vol. 94, Iss. 5, pp. 509-522
Closed Access | Times Cited: 328

Tumor neoantigens: from basic research to clinical applications
Tao Jiang, Tao Shi, Henghui Zhang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 325

Acidic tumor microenvironment and pH-sensing G protein-coupled receptors
Calvin R. Justus, Lixue Dong, Li V. Yang
Frontiers in Physiology (2013) Vol. 4
Open Access | Times Cited: 323

Page 1 - Next Page

Scroll to top